<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>the Lancet Commission on Precision Health | CEPID BRAINN</title>
	<atom:link href="https://www.brainn.org.br/en/tag/the-lancet-commission-on-precision-health/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.brainn.org.br/en</link>
	<description>powered by FAPESP</description>
	<lastBuildDate>Thu, 02 Jul 2026 10:58:25 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.brainn.org.br/wp-content/uploads/2020/05/cropped-CEPID-BRAINN-favicon-32x32.png</url>
	<title>the Lancet Commission on Precision Health | CEPID BRAINN</title>
	<link>https://www.brainn.org.br/en</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>The Lancet&#8217;s international commission seeks to expand access to precision medicine.</title>
		<link>https://www.brainn.org.br/en/comissao-internacional-da-the-lancet-busca-ampliar-acesso-a-medicina-de-precisao/</link>
					<comments>https://www.brainn.org.br/en/comissao-internacional-da-the-lancet-busca-ampliar-acesso-a-medicina-de-precisao/#respond</comments>
		
		<dc:creator><![CDATA[BRAINN]]></dc:creator>
		<pubDate>Thu, 02 Jul 2026 10:58:25 +0000</pubDate>
				<category><![CDATA[]]></category>
		<category><![CDATA[Íscia Lopes-Cendes]]></category>
		<category><![CDATA[Medicina de precisão]]></category>
		<category><![CDATA[The Lancet]]></category>
		<category><![CDATA[the Lancet Commission on Precision Health]]></category>
		<guid isPermaLink="false">https://www.brainn.org.br/?p=17024</guid>

					<description><![CDATA[<p>Article in *Jornal da Unicamp* highlights the work of The Lancet Commission on Precision Health regarding the adoption of precision medicine in public health systems. Text by: Daniela Prandi  &#160; Often associated with sophisticated exams and high-cost treatments, precision medicine is still seen as a reality restricted to highly specialized centers. A new international commission [&#8230;]</p>
The post <a href="https://www.brainn.org.br/en/comissao-internacional-da-the-lancet-busca-ampliar-acesso-a-medicina-de-precisao/">The Lancet’s international commission seeks to expand access to precision medicine.</a> first appeared on <a href="https://www.brainn.org.br/en">CEPID BRAINN</a>.]]></description>
										<content:encoded><![CDATA[<p><em>Article in *Jornal da Unicamp* highlights the work of The Lancet Commission on Precision Health regarding the adoption of precision medicine in public health systems.</em></p>
<p><span id="more-17024"></span></p>
<p><span style="color: #808080;"><em>Text by: Daniela Prandi </em></span></p>
<p>&nbsp;</p>
<p>Often associated with sophisticated exams and high-cost treatments, precision medicine is still seen as a reality restricted to highly specialized centers. A new international commission created by the scientific journal The Lancet, titled “The Lancet Commission on Precision Health”The group aims to change this perception. It brings together more than 20 experts from various countries, including Iscia Lopes-Cendes, a professor at the Faculty of Medical Sciences (FCM) at Unicamp and a researcher at the Brazilian Institute of Neuroscience and Neurotechnology (Cepid-Brainn), based at Unicamp.</p>
<p>Lopes-Cendes, a specialist in genomic medicine and technologies applied to neuroscience, is one of two representatives from Latin America in the group, which also includes psychiatrist Christian Kieling from the Federal University of Rio Grande do Sul (UFRGS). According to her, the commission&#8217;s objective is to formulate recommendations so that precision health strategies can be equitably incorporated into health systems worldwide.</p>
<p>In this process, he emphasizes, Brazil can play an important role. &#8220;I see Brazil as having a great responsibility to do the right thing, because we are a showcase for other countries in Latin America and for countries in the Global South.&#8221;</p>
<p>According to Lopes-Cendes, the country occupies a strategic position because it possesses characteristics that can transform it into a benchmark. &#8220;We can implement this equitably because, as long as it occurs within the Unified Health System (SUS), which has enormous reach, it will benefit all Brazilians.&#8221;</p>
<p>The researcher emphasizes that the combination of a universal public system, the increasing integration of health databases, and the accumulated experience in prevention policies puts Brazil in a privileged position to test models that can later be replicated in other regions of the world.</p>
<p>“Given Brazil’s characteristics—a country that produces a great deal of statistics and is currently transitioning to a higher level of development—there is significant international interest in what happens here. Brazilian case studies may be published within the commission. Our healthcare system is very organized in terms of record-keeping and data production, and this allows for the development of very interesting research,” she added.</p>
<p>The commission was created to address a growing challenge in healthcare systems. Although scientific advances have demonstrated that genetic, environmental, behavioral, and social factors influence the onset of diseases and the response to treatments, most medical care is still based on population averages and standardized protocols. The so-called precision health seeks precisely to incorporate this diversity. &#8220;We decided not to call the commission &#8216;precision medicine,&#8217; but &#8216;precision health,&#8217; because we can recommend actions related to lifestyle, behavior, and even public policies,&#8221; she explains.</p>
<p>&nbsp;</p>
<a href="https://jornal.unicamp.br/en/noticias/2026/06/11/comissao-internacional-da-the-lancet-busca-ampliar-acesso-a-medicina-de-precisao/" class="su-button su-button-style-glass" style="color:#ffffff;background-color:#3f175f;border-color:#33134c;border-radius:6px" target="_blank" rel="noopener noreferrer"><span style="color:#ffffff;padding:6px 18px;font-size:14px;line-height:21px;border-color:#795d8f;border-radius:6px;text-shadow:none"><i class="sui sui-paperclip" style="font-size:14px;color:#ffffff"></i> Read the full article here</span></a>The post <a href="https://www.brainn.org.br/en/comissao-internacional-da-the-lancet-busca-ampliar-acesso-a-medicina-de-precisao/">The Lancet’s international commission seeks to expand access to precision medicine.</a> first appeared on <a href="https://www.brainn.org.br/en">CEPID BRAINN</a>.]]></content:encoded>
					
					<wfw:commentRss>https://www.brainn.org.br/en/comissao-internacional-da-the-lancet-busca-ampliar-acesso-a-medicina-de-precisao/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Precision medicine for all: an introduction to The Lancet Commission on Precision Health</title>
		<link>https://www.brainn.org.br/en/medicina-de-precisao-para-todos-conheca-a-the-lancet-commission-on-precision-health/</link>
					<comments>https://www.brainn.org.br/en/medicina-de-precisao-para-todos-conheca-a-the-lancet-commission-on-precision-health/#respond</comments>
		
		<dc:creator><![CDATA[BRAINN]]></dc:creator>
		<pubDate>Tue, 09 Jun 2026 13:40:39 +0000</pubDate>
				<category><![CDATA[Destaques]]></category>
		<category><![CDATA[Medicina de precisão]]></category>
		<category><![CDATA[saúde de precisão]]></category>
		<category><![CDATA[The Lancet]]></category>
		<category><![CDATA[the Lancet Commission on Precision Health]]></category>
		<guid isPermaLink="false">https://www.brainn.org.br/?p=16969</guid>

					<description><![CDATA[<p>The initiative includes BRAINN researcher Iscia Lopes‑Cendes and aims to expand the reach of precision medicine within a complex global socioeconomic landscape. &#160; Precision medicine for all — this is the objective of a new global initiative that seeks to broaden the scope of precision health (a term encompassing both disease prevention and treatment), deploying [&#8230;]</p>
The post <a href="https://www.brainn.org.br/en/medicina-de-precisao-para-todos-conheca-a-the-lancet-commission-on-precision-health/">Precision medicine for all: an introduction to The Lancet Commission on Precision Health</a> first appeared on <a href="https://www.brainn.org.br/en">CEPID BRAINN</a>.]]></description>
										<content:encoded><![CDATA[<p><em>The initiative includes BRAINN researcher Iscia Lopes‑Cendes and aims to expand the reach of precision medicine within a complex global socioeconomic landscape.</em></p>
<p><span id="more-16969"></span></p>
<p>&nbsp;</p>
<p><em><strong><a href="https://www.brainn.org.br/annual-reviews-como-integrar-genomica-medicina-de-precisao-e-sistemas-de-saude-na-america-latina/"><span style="text-decoration: underline;">Precision medicine</span></a> for all</strong></em> — this is the objective of a new global initiative that seeks to broaden the scope of <em>precision health</em> (a term encompassing both disease prevention and treatment), deploying cutting‑edge technologies across diverse socioeconomic contexts.</p>
<p>The The Lancet Commission on Precision Health, of which CEPID BRAINN researcher Dr. <span style="text-decoration: underline;"><a href="https://www.brainn.org.br/grupo-consultivo-tecnico-sobre-genomica-tag-g-da-oms-presidido-pela-pesquisadora-iscia-lopes-cendes-publica-artigo-na-nature-medicine/"><strong>Iscia Lopes‑Cendes</strong></a></span> is a member, intends to translate medical, scientific, technological and analytical advances into effective, equitable and financially sustainable health interventions that account for the social, cultural and economic characteristics of specific populations. This is precision medicine in practice, tested in real‑world settings. Below is a summary of the project.</p>
<p>&nbsp;</p>
<p><em><strong>See also</strong></em></p>
<blockquote class="wp-embedded-content" data-secret="Be8QMchlcR"><p><a href="https://www.brainn.org.br/annual-reviews-como-integrar-genomica-medicina-de-precisao-e-sistemas-de-saude-na-america-latina/">Annual Reviews: como integrar Genômica, Medicina de Precisão e sistemas de saúde na América Latina?</a></p></blockquote>
<p><iframe class="wp-embedded-content" sandbox="allow-scripts" security="restricted"  title="“Annual Reviews: como integrar Genômica, Medicina de Precisão e sistemas de saúde na América Latina?” — CEPID BRAINN" src="https://www.brainn.org.br/annual-reviews-como-integrar-genomica-medicina-de-precisao-e-sistemas-de-saude-na-america-latina/embed/#?secret=zsDWJ4vAXV#?secret=Be8QMchlcR" data-secret="Be8QMchlcR" width="500" height="282" frameborder="0" marginwidth="0" marginheight="0" scrolling="no"></iframe></p>
<p>&nbsp;</p>
<h2><strong>The era of one‑size‑fits‑all treatment is over</strong></h2>
<p>Many of the world’s most common and serious diseases (such as cardiovascular disease, mental health disorders and cancer) do not affect all individuals in the same way. Disease etiology and treatment responses can vary substantially between individuals and across populations. Nevertheless, most health systems still employ a <em>one‑size‑fits‑all</em> approach, which constrains therapeutic efficacy and the equity of care.</p>
<p>According to researchers from The Lancet Commission, this unified approach to disease management made sense until recently, prior to the major medical, technological and data‑processing advances of the last decades.</p>
<p>“Most modern healthcare is based on population averages — adopting an approach that assumes what works on average will work for each individual,” the group states.</p>
<blockquote><p>“This ‘one‑size‑fits‑all’ model was reasonable when we lacked tools to predict disease risk or treatment response with precision. Today, however, we know that people differ markedly in how diseases develop and how treatments perform, depending on their genetics, environment, behavior and access to healthcare.”</p></blockquote>
<p>&nbsp;</p>
<h2><strong>About the Commission</strong></h2>
<p>The The Lancet Commission on Precision Health aims to change this paradigm by developing prevention and care strategies that make healthcare more effective and equitable worldwide. The group’s stated goal is “to ensure that the benefits of precision medicine reach all populations, not only a privileged few.”</p>
<div id="attachment_16977" style="width: 2457px" class="wp-caption aligncenter"><img fetchpriority="high" decoding="async" aria-describedby="caption-attachment-16977" class="wp-image-16977 size-full" src="https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1.jpg" alt="The Lancet Commission on Precision Health - Figure 1" width="2447" height="1167" srcset="https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1.jpg 2447w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-300x143.jpg 300w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-1024x488.jpg 1024w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-768x366.jpg 768w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-1536x733.jpg 1536w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-2048x977.jpg 2048w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-419x200.jpg 419w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-82x39.jpg 82w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-100x48.jpg 100w, https://www.brainn.org.br/wp-content/uploads/2026/06/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-156x74.jpg 156w" sizes="(max-width: 2447px) 100vw, 2447px" /><p id="caption-attachment-16977" class="wp-caption-text"><em>Working model of the Commission for precision health studies. Source: <a href="https://www.theprecisionhealthcommission.org/about/" target="_blank" rel="noopener">official website</a> of the group</em></p></div>
<p>&nbsp;</p>
<p>Precision‑based strategies have already been implemented successfully in high‑income countries using advanced (and costly) technologies, particularly in oncology. The Commission seeks to demonstrate that these examples do not exhaust the potential of this medical‑scientific approach, which can also be adopted in settings with greater economic and technological constraints. In other words, there are accessible, low‑cost opportunities that can help scale precision medicine globally.</p>
<blockquote><p><em>Precision Health considers an individual’s genetic, biological and environmental characteristics to design tailored therapeutic strategies. This enables improvements in treatment duration and effectiveness, as well as in preventive measures.</em></p></blockquote>
<p>The group will examine the application of precision health both for disease prevention (through lifestyle changes, behavioral interventions and pharmacotherapies) and for disease management (including diagnostics, therapies, prognostics and monitoring), comparing health outcomes and quality of life of subgroups and individuals against traditional standardized treatments.</p>
<p>The Commission comprises more than 20 researchers from around the world. Latin America is represented by CEPID BRAINN physician‑researcher Dr. Iscia Lopes‑Cendes, an expert in genomic medicine and multi‑omics technologies applied to neuroscience, and by Dr. Christian Kieling from the Federal University of Rio Grande do Sul.</p>
<p>The Commission will operate for approximately three years, having been formally launched in January 2026. The group’s studies, analyses, findings and recommendations will be published periodically in The Lancet, one of the world’s leading scientific journals.</p>
<p>&nbsp;</p>
<h3><strong>For further reading</strong></h3>
<p>For more details and information, consult the official launch announcement in The Lancet and the links below.</p>
<ul>
<li>Franks PW, Lim LL, Ramsay M, Chotirmall SH, Abedalthagafi MS, Ali R, K SB, Ford J, Giordano GN, Hamdi Y, Kieling C, Leal J, Li F, Lopes‑Cendes I, Lyons L, Misra S, Owolabi MO, Rosenquist R, Tandon N, Tsosie KS, Udler MS, Smeden MV, Verguet S, Wason J. The Lancet Commission on precision health: equitable, data‑driven health outcomes for all. Lancet. 2026 May 25:S0140-6736(26)00612-4. doi: 10.1016/S0140-6736(26)00612-4. Epub ahead of print. PMID: 42184810.</li>
<li>See the Commission’s publications list: <span style="text-decoration: underline;"><a href="https://www.theprecisionhealthcommission.org/publications/" target="_blank" rel="noopener">https://www.theprecisionhealthcommission.org/publications/</a></span></li>
<li>Visit the official website: <span style="text-decoration: underline;"><a href="https://www.theprecisionhealthcommission.org/" target="_blank" rel="noopener">https://www.theprecisionhealthcommission.org/</a></span></li>
</ul>
<p>&nbsp;</p>The post <a href="https://www.brainn.org.br/en/medicina-de-precisao-para-todos-conheca-a-the-lancet-commission-on-precision-health/">Precision medicine for all: an introduction to The Lancet Commission on Precision Health</a> first appeared on <a href="https://www.brainn.org.br/en">CEPID BRAINN</a>.]]></content:encoded>
					
					<wfw:commentRss>https://www.brainn.org.br/en/medicina-de-precisao-para-todos-conheca-a-the-lancet-commission-on-precision-health/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
